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The biopharmaceutical industry is approaching a turning point where new therapeutic modalities such as virusbased biopharmaceuticals are used in several applications such as vaccination, gene therapy and oncolytic
therapy. However, the bioprocess of functional viruses still presents challenges, namely due to the availability of
suitable analytics for downstream processing monitoring or characterization of the final product. Capillary
electrophoresis (CE) is a versatile technique that enables the determination of intact or reduced particle number
and the quantification of several product-related impurities, such as host cell DNA and host cell proteins.
Although this f platform is commonly used for purity profiling of monoclonal antibodies in the pharmaceutical
industry by ultraviolet (UV) detection, it requires a large amount of product, making it not suitable for virus-based
pharmaceuticals, where total protein concentration (dose) is relatively low.
This work presents a highly sensitive CE methodology for monitoring different bioprocess steps and final
product characterization of several viral vectors. A fluorescence labelling procedure using the (3-(2-furoyl)
quinoline-2-carboxaldehyde dye was used, enabling the detection of the viral proteins through Sodium dodecyl
sulfate-capillary gel electrophoresis (CE-SDS) method coupled to a laser-induced fluorescence (LIF) detector.
Sample purity and capsid protein content of several recombinant Adeno-associated virus (rAAV) serotypes
produced in different cell systems were analysed regarding their viral protein VP1/VP3 ratio, a known critical
quality attribute for these vectors. Moreover, the evaluation of in-process rAAV samples enabled the detection of
residual process-related impurities, such as adenoviral proteins from the HelaS3-based production system. The
method was also validated for the quantification of - rAAV2 following the ICH guidelines.
The lack of bioprocess monitoring is especially significant for enveloped viruses, which present an outer
lipoprotein layer which is more sensitive to the processing conditions. To evaluate method suitability for
enveloped viral targets, in-process samples from lentiviral vectors were analysed. Differences in the envelope
protein were detected, a consequence of the purification processing conditions. This approach was compared
with other similar analytical tools, CE-SDS with UV detector and SDS-PAGE, results confirmed the increased
sensibility of the implemented technique. The potential applicability of the CE-SDS-LIF methodology for the
evaluation of the viral vector construction quality was also demonstrated. The differences between a vesicular
stomatitis virus (VSV) Maraba viral vector (MG1) and a chimeric viral vector based on VSV genome were
confirmed, by showing the lack of glycoprotein G in the chimeric vector, responsible for reducing the off-target
toxicity associated with wild-type VSV.
Overall, the work performed enabled the implementation of a novel, robust and sensitive analytical platform for
in-process sample analysis and quantification of different viral-based targets.
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